Efficacy of preoperative carbohydrate drink containing standardized ginger extract in patients undergoing endoscopic ultrasound: arandomized controlled trial

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

TCTR

Registry ID

TCTR20260219005

Enrollment

120

Registered

2026-02-19

Start date

2026-02-18

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patient schedule for EUS Oral carbohydrate EUS Enhanced recovery after surgery Satisfy

Interventions

Receives a carbohydrate drink containing standardized ginger extract (50 g carbohydrate in 250 mL solution) 2.5 to 4 hours before EUS.,Receives 250 mL of colored water (placebo) 2.5 to 4 hours before

Active Comparator Drug,Placebo Comparator Other

EUS group,Placebo

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Adults aged 18 years or older. 2. Scheduled to undergo Endoscopic ultrasound (EUS) for appropriate medical indications, including planned diagnostic or therapeutic procedures such as EUS-guided fine-needle aspiration (EUS-FNA), EUS-guided fine-needle biopsy (EUS-FNB), or EUS-guided drainage. 3. Provide written informed consent voluntarily to participate in the study.

Exclusion criteria

Exclusion criteria: 1. Patients with contraindications to oral intake, such as gastric outlet obstruction or intestinal obstruction. 2. Patients with active infection or recent recovery from infection with defervescence less than 72 hours. 3. Patients with hemodynamic instability. 4. Patients with a history of allergy to ginger or related herbal extracts (e.g., ginger extract, members of the Zingiberaceae family). 5. Patients with altered level of consciousness or inability to communicate effectively. 6. Patients with cognitive impairment or psychiatric disorders that may interfere with outcome assessment. 7. Patients with severe dysphagia requiring nasogastric or gastrostomy tube feeding. 8. Pregnant women. 9. Patients currently using GLP-1 receptor agonists or who discontinued them less than 4 weeks prior to enrollment. 10. Patients with poorly controlled diabetes mellitus (HbA1c more than 9%) or pre-procedural blood glucose >300 mg/dL.

Design outcomes

Primary

Measure	Time frame
Patient comfort scores including Hunger, Thirst . Anxiety. Fatigue , Nausea and Abdominal discomfort 4 hours after EUS Visual analog score	—

Secondary

Measure	Time frame
Safety Peri procedure Event,Gastric Residual Volume Peri procedure Measurement of gastric residual volume,Inflammation Before and 4 hour after procedure Laboratory,Amylase Before and 4 hour after procedure Laboratory,Blood sugar Before and 4 hour after procedure Laboratory	—

Countries

Thailand

Contacts

Public ContactThanawin Saewong

NKC institute, Songklanakarind hospital

wongthanawin68@gmail.com074451967

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026